David DeLucia | Director of Investor Relations |
Robert Finizio | Chief Executive Officer and Co-Founder |
Daniel Cartwright | Chief Financial Officer |
Brian Bernick | Co-Founder and Chief Clinical Officer |
Sebastian Mirkin | Chief Medical Officer |
Annabel Samimy | Stifel, Nicolaus & Co., Inc. |
Esther Rajavelu | Deutsche Bank |
Ken Cacciatore | Cowen & Co LLC. |
Jay Olson | Oppenheimer & Co. Inc. |
Matthew Andrews | Jefferies LLC |
Thomas Smith | Morgan Stanley |
Caroline Palomeque | NOBLE Capital Markets, Inc. |
Good morning, ladies and gentlemen, thank you for joining us for the TherapeuticsMD Fourth Quarter and Full-Year 2017 Financial Results Conference Call.
Following prepared remarks from the Company, we will open the call for questions. I would now like to turn the call over to Therapeutics’ Director of Investor Relations, David DeLucia. David?
Good afternoon, everyone.